Dicerna Pharmaceuticals
DRNA
#4022
Rank
A$4.45 B
Marketcap
A$57.13
Share price
0.00%
Change (1 day)
15,977.75%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: A$4.45 Billion

As of January 2026 Dicerna Pharmaceuticals has a market cap of A$4.45 Billion. This makes Dicerna Pharmaceuticals the world's 4022th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022A$4.37 B6.54%
2021A$4.10 B89.24%
2020A$2.17 B-3.62%
2019A$2.25 B117.58%
2018A$1.03 B73.29%
2017A$0.59 B620.38%
2016A$82.91 M-75.29%
2015A$0.33 B-6.25%
2014A$0.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
A$0.84 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$14.12 B 217.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$216.24 B 4,758.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$71.91 B 1,515.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$412.32 B 9,164.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$265.41 B 5,863.30%๐Ÿ‡บ๐Ÿ‡ธ USA